LONDON – IBM Corp. and the Institute of Bioengineering and Nanotechnology in Singapore have shown that nanometer-scale polymeric chemicals can seek out and destroy antibiotic-resistant bacteria and infectious diseases such as Methicillin-resistant Staphylococcus aureus (MRSA).
The MRSA breakthrough applies self-organizing principles used in semiconductor engineering, IBM said. The polymers are biodegradable nanostructures that are physically attracted to the infected cells so that they selectively in application and do not damage healthy cells. The nanostructures also physically break through the bacterial cell wall and thereby prevent bacteria from evolving and developing resistance.
The polymers are designed so that they become active only when they come into contact with water or are introduced into the body. They then self-assemble into a new structure that attacks bacterial membranes based on electrostatic interaction. On this basis it only attacks the bacterial cells and the polymer structures are biodegradable, so that they are eliminated from the body over time and do not accumulate in organs.
The antimicrobial polymers, created by IBM Research and the Institute of Bioengineering and Nanotechnology, were tested against clinical microbial samples by the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine and Zhejiang University in China. The full research paper was recently published in the peer-reviewed journal Nature Chemistry.
"The number of bacteria in the palm of a hand outnumbers the entire human population," said James Hedrick, advanced organic materials scientist at IBM Research – Almaden, in a statement. "With this discovery we've been able to leverage decades of materials development traditionally used for semiconductor technologies to create an entirely new delivery mechanism that could make drugs more specific and effective."
If commercially manufactured, these biodegradable nanostructures could be injected directly into the body or applied topically to the skin, treating skin infections through consumer products such as: deodorant, soap, hand sanitizer, table wipes and preservatives, as well as be used to help heal wounds, tuberculosis and lung infections.
Wow, this is really a major breakthrough. This is the first time semiconductor technology is being used for Diagnosis and Treatment of infectious Diseases.
Peter, When can we expect the commercial version of these biodegradable nanostructures ?
David Patterson, known for his pioneering research that led to RAID, clusters and more, is part of a team at UC Berkeley that recently made its RISC-V processor architecture an open source hardware offering. We talk with Patterson and one of his colleagues behind the effort about the opportunities they see, what new kinds of designs they hope to enable and what it means for today’s commercial processor giants such as Intel, ARM and Imagination Technologies.